POLATUZUMAB VEDOTIN for Lymphoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 48 adverse event reports in the FDA FAERS database where POLATUZUMAB VEDOTIN was used for Lymphoma.
Most Reported Side Effects for POLATUZUMAB VEDOTIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Disease progression | 1,131 | 23.9% | 234 | 146 |
| Off label use | 692 | 14.6% | 97 | 113 |
| Anaemia | 344 | 7.3% | 48 | 127 |
| Blood lactate dehydrogenase increased | 307 | 6.5% | 66 | 49 |
| Drug ineffective | 305 | 6.4% | 72 | 52 |
| Neutropenia | 303 | 6.4% | 55 | 102 |
| Death | 295 | 6.2% | 295 | 52 |
| Covid-19 | 286 | 6.0% | 71 | 116 |
| Febrile neutropenia | 286 | 6.0% | 37 | 197 |
| Pyrexia | 285 | 6.0% | 46 | 156 |
| Thrombocytopenia | 265 | 5.6% | 56 | 103 |
| Lymphoma | 257 | 5.4% | 32 | 11 |
| Platelet count decreased | 256 | 5.4% | 47 | 77 |
| Neutrophil count decreased | 252 | 5.3% | 35 | 97 |
| Diffuse large b-cell lymphoma | 249 | 5.3% | 60 | 23 |
Other Indications for POLATUZUMAB VEDOTIN
Diffuse large b-cell lymphoma (3,196)
Product used for unknown indication (282)
B-cell lymphoma (281)
Diffuse large b-cell lymphoma refractory (223)
Non-hodgkin's lymphoma (169)
Follicular lymphoma (159)
Diffuse large b-cell lymphoma recurrent (98)
Diffuse large b-cell lymphoma stage iv (76)
Richter's syndrome (54)
Lymphoma transformation (33)
Other Drugs Used for Lymphoma
RITUXIMAB (3,142)
CYCLOPHOSPHAMIDE (1,729)
VINCRISTINE (1,452)
LENALIDOMIDE (1,427)
DOXORUBICIN (1,420)
ETOPOSIDE (915)
IBRUTINIB (896)
PREDNISONE (672)
METHOTREXATE (647)
CYTARABINE (645)